Clinical trial
Relative Bioavailability of PM101 IV and Cordarone IV
NCT00420953 · Prism Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00420953 |
|---|---|
| Title | Relative Bioavailability of PM101 IV and Cordarone IV |
| Official title | A Randomized, Double-blind, 2-period Crossover Trial to Determine the Relative Bioavailability of PM101 I.V. (Amiodarone HCl) and Cordarone I.V. in Healthy Adult Volunteers |
| Lead sponsor | Prism Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Cordarone |
| Start date | Dec 18, 2006 |
| Primary completion | Apr 23, 2007 |
| Completion | Apr 23, 2007 |
| First posted | Jan 11, 2007 |
| Last update posted | Sep 8, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: